Description
This procedure analyzes cell-free DNA from a plasma specimen to identify genetic variants associated with solid organ tumors. It evaluates critical factors such as microsatellite instability and tumor mutation burden, which can guide personalized treatment strategies.
—
—
No modifiers found.
No crosswalks found.
No alternates found.
No codes found here.
We make no claims to ownership of the coding systems referenced on this platform. Codes and descriptions are produced from claims and chargemaster data available through the CMS-9915-F Transparency in Coverage Final Rule and via state or federal datasets. This service is provided solely as a reference to encourage use of these codes in our chargemaster review and automated billing tools, so that healthcare professionals can understand and correctly report these codes in their claims.